|
|
CSL meets with US Federal Trade Commissioners regarding Talecris Acquisition
CSL meets with US Federal Trade Commissioners regarding Talecris Acquisition
Melbourne, Australia — 25/05/2009
CSL Limited today announced that Managing Director, Dr Brian McNamee, met with U.S. Federal Trade Commission (FTC) Commissioners in Washington DC on 22 May to discuss CSL's proposed acquisition of Talecris Biotherapeutics, Inc. Download this release:
 CSL meets with US Federal Commissioners regarding Talecris Acquisition  (0.84 MB) | Media Contacts: | | Dr Rachel David
Director, Public Affairs
CSL Limited
Telephone: +613 9389 1821
Email: rachel.david@csl.com.au
| Tim Duncan
Hinton & Associates
Telephone: +613 9600-1979
Email: tduncan@hintons.com.au
| | Investor Contact: | | Mark Dehring
Head of Investor Relations
CSL Limited
Telephone: +613 9389 2818
Email:
mark.dehring@csl.com.au | |
|